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Abstract
Objective Early treatment of phenylketonuria (ET-PKU) pre-
vents mental retardation, but many patients still show cogni-
tive and mood problems. In this study, it was investigated
whether ET-PKU-patients have specific phenylalanine
(Phe-)related problems with respect to social-cognitive func-
tioning and social skills.
Methods Ninety five PKU-patients (mean age 21.6
± 10.2 years) and 95 healthy controls (mean age 19.6
±8.7 years) were compared on performance of computerized
and paper-and-pencil tasks measuring social-cognitive
abilities and on parent- and self-reported social skills, using
multivariate analyses of variance, and controlling for general
cognitive ability (IQ-estimate). Further comparisons were
made between patients using tetrahydrobiopterin (BH4,
N=30) and patients not using BH4. Associations with Phe-
levels on the day of testing, during childhood, during adoles-
cence and throughout life were examined.
Results PKU-patients showed poorer social-cognitive func-
tioning and reportedly had poorer social skills than controls
(regardless of general cognitive abilities). Quality of social-
cognitive functioning was negatively related to recent Phe-
levels and Phe-levels between 8 and 12 years for adolescents
with PKU. Quality of social skills was negatively related to
lifetime phenylalanine levels in adult patients, and specifically
to Phe-levels between 0 and 7, and between 8 and 12 years.
There were no differences with respect to social outcomemea-
sures between the BH4 and non-BH4 groups.
Conclusion PKU-patients have Phe-related difficulties with
social-cognitive functioning and social skills. Problems seem
to be more evident among adolescents and adults with PKU.
High Phe-levels during childhood and early adolescence seem
to be of greater influence than current and recent Phe-levels
for these patients.
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Introduction
In phenylketonuria (PKU; OMIM 212600), the brain dysfunc-
tion is, at least in part, considered to be the result of dopamine
and serotonin deficiency (Blau et al 2010). Dopamine deple-
tion has repeatedly been related to deficits in executive func-
tion (EF), which is the most frequently reported cognitive
deficit in ET-PKU (Christ et al 2010), but also with impair-
ments in social cognition (Skuse and Gallagher 2009).
Decrease of serotonin activity has also been associated with
(orbitofrontal cortex-mediated) EF-problems (Gellynck et al
2013), deficits in social cognition and social behaviour, and
with mood disorders (Kiser et al 2012; Lesch and Waider
2012). Whereas a Phe-restricted diet with amino acid supple-
ments is still the most widely-used treatment strategy for
PKU, a sub-group of patients benefits (at least with respect
to keeping Phe-levels in the lower ranges) from the use of
tetrahydrobiopterin (BH4), which is a co-factor of the deficient
enzyme phenylalanine hydroxylase (PAH). In many patients
Phe-levels clearly rise after childhood, which, in turn, may
affect dopamine and serotonin levels (MacDonald et al
2010; Trefz et al 2011). Higher Phe-levels are permitted in
many national guidelines, and it is not yet fully clear what
the upper target Phe-levels should be in adolescence and
adulthood in relation to cognitive ability, social and behav-
ioural functioning, necessitating more research in these
age groups.
Social cognition involves all mental processes that underlie
social interactions and comprises the ability to perceive, to
interpret and to respond appropriately to social cues. Basic
social-cognitive skills include face recognition, emotion rec-
ognition and Theory ofMind (ToM), i.e. the ability to attribute
and understand thoughts, feelings and intentions to/of other
people (Hughes and Leekam 2004). Although social cognition
and social functioning have not yet been studied extensively
in PKU, it seems likely that the consistently reported EF-
problems (Christ et al 2010) extend to these domains, because
of shared underlying neurobiology and neuro-anatomy
(Arnsten and Rubia 2012; Heinz et al 2011; Murphy et al
2002). Also, several mental health problems, characterized
by social (-cognitive) impairments, such as mood swings
and depression, have been observed in PKU (Anjema et al
2011; Jahja et al 2013; Ten Hoedt et al 2011). In PKU a lack
of autonomy and a low rate of forming normal adult relation-
ships have been observed, although among early- and well-
treated patients, such problems seem quite rare (Bosch et al
2007; Simon et al 2008).
The goal of the present study was to investigate social
cognition and social skills of PKU-patients in relation to met-
abolic control, i.e. historical and concurrent Phe. As adherence
is increasingly difficult with age, and because social demands
increase from adolescence onwards, we hypothesized that
problems would become more serious with increasing age,
being the most severe in adults with PKU.
It was further expected that, in concordance with well-
documented Phe-EF/IQ associations (Huijbregts et al 2002;
Waisbren et al 2007), problems with social cognition and so-
cial skills would be related to both historical and concurrent
Phe, with somewhat stronger associations for historical Phe-
levels.
Method
Participants
The PKU group consisted of 95 patients (41 males, 54 fe-
males, mean age 21.6 years ± 10.2, range 7.0–42.8 years).
All patients were born in or after 1974, when neonatal screen-
ing was introduced in The Netherlands, and were treated since
diagnosis early after birth. All patients paid regular follow-up
visits to one of six Dutch university medical centres (and were
treated according to National Instituted of Health (NIH)
guidelines, published in 2000). The healthy matched control
group included 95 subjects (30 males, 65 females, mean age
19.6 years±8.7, range 7.2–40.8 years). Seven controls were
siblings or cousins of the patients. The PKU and control groups
did not differ significantly in age and gender distribution
(Table 1). No differences were observed regarding SES-
related measures (e.g. mean family income or achieved educa-
tion levels) either. Although in the normal range, the PKU
group had a lower IQ (101± 12) than controls (108± 13):
t(186)=3.8, p<0.001.
Blood samples were taken from the patients preprandially
at home on the day of neuropsychological testing, which took
place at the patients’ clinics. Historical Phe-levels were col-
lected from hospital databases. Lifetime Phe was calculated as
the mean of half-year median Phe-levels, from birth until the
day of testing. Also, Phe-levels between 0–7, 8–12, 13–17 and
≥18 years were calculated when applicable, to gain more in-
sight into Phe-levels during particular developmental stages.
PKU-patients had a mean concurrent Phe-level of 556 μmol/
L±328. Mean lifetime Phe was 399 μmol/L±154 (n=92;
lifetime Phe of three patients was for the larger part
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incomplete and could therefore not be calculated) (Table 1).
Concurrent and lifetime Phe were correlated with each other
(r=0.67, p<0.001). Age was significantly related to concur-
rent (r=0.37, p<0.001) and lifetime Phe (r=0.55, p<0.001),
indicating higher Phe-levels for older patients. Historical Phe-
levels between 0 and 7 years were higher for adults with PKU
than for children and adolescents with PKU (F(2,88)=3.2,
p=0.046).
Thirty patients used tetrahydrobiopterin (BH4-) doses up to
20 mg/kg with a maximum of 1400 mg/day. The BH4 group
was younger (mean age 15.8±8.5) than the non-BH4 group
(mean age 24.4 ± 9.9): t(65) = 4.4, p < 0.001. Lifetime
(t(90) = 6.3, p < 0.001) and concurrent Phe (t(90) = 5.0,
p<0.001) were lower for the BH4 group.
Instruments
Children performed three tasks to measure social-cognitive abil-
ities; adolescents and adults performed four tasks. In order to
assess social skills, for children and adolescents the Social
Skills Rating System (SSRS; Gresham and Elliot 1990) was
filled out by parents, whereas adults filled out the Social Skills
Checklist-Self Report (SSC-SR; Novotni 2000). Subtests
Vocabulary and Block Design from the Wechsler Intelligence
Scale for Children (WISC-III, Wechsler 1991) or the Wechsler
Adult Intelligence Scale (WAIS-III,Wechsler 1997) were used to
estimate verbal and performance IQ.
Two tasks were performed by all participants: the computer-
ized Face Recognition and (FR) and Identification of Facial
Emotions (IFE) tasks from the Amsterdam Neuropsychological
Tasks (ANT; De Sonneville 2014). FR examines how fast and
how well participants are able to recognize neutral faces and
consists of three parts (40 trials each): faces were presented from
the front, ‘en profile’, and upside down. Each trial is preceded by
a target face, after which participants have to decide whether the
subsequent signal, containing four faces, includes the target face.
In the IFE, participants identify facial emotions as quickly and
accurately as possible. The task has four parts (40 trials each),
where consecutively happy, sad, angry and frightened faces have
to be identified. The mean of age-corrected z-scores for accuracy
andRTon the FR and IFEwas calculated, and converted so that a
higher score indicated a better performance, leading to one over-
all z-score representing social cognition as measured by comput-
erized tasks.
One task was performed only by children up to the age of 12.
This paper-and-pencil (P&P-) task, the Social Cognitive Skills
Test (Van Manen et al 2007), examines ToM-skills. The task
consists of seven stories with associated pictures. After each
story, questions were asked representing eight aspects of ToM,
leading to a total score with four levels. The standardized total
score was used as dependent variable. A high score indicates
better ToM. Two tasks were performed only by adolescents
and adults. These P&P-tasks, the Faux-Pas Recognition TestTa
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(FPT; Baron-Cohen et al 1999) and the Reading the Mind in the
Eyes (RME-) task (Baron-Cohen et al 2001) measure ToM. FPT
measures how one interprets social situations that are potentially
awkward (‘faux pas’). It consists of five stories containing a faux
pas and four control stories, followed by questions about the
social occurrence in the story. A higher score indicates a better
ability to interpret social situations. This score was again stan-
dardized for statistical analyses. RMEmeasures howwell mental
states of others are understood based solely on information from
the eyes. The test consists of 36 photographs of eye regions of
individuals, of which participants have to identify the best fitting
emotion from four possible answers. A higher (standardized)
score indicates a better ability to recognize emotions. Mean z-
score for accuracy of the three P&P-tasks was used in statistical
analyses.
Regarding the questionnaires, the SSRS consists of 38 items,
measuring social skills on four different dimensions (coopera-
tion, assertiveness, responsibility and self-control), thereby using
3-point rating scales. Higher scores represent better social skills.
The SSC consists of 81 items, measuring social skills on eight
different dimensions (basic manners, nonverbal and verbal com-
munication, communication roadblocks, organizational skills,
self-control, knowledge, relationships and self-care), using 3-
point rating scales. Higher scores indicate better social skills.
Standardized mean score for the SSRS and SSC-R was used to
represent the level of social skilfulness.
Data analyses
As noted, standardized scores, calculated separately for the com-
puterized tasks, P&P-tasks and questionnaires were used in sta-
tistical analyses (performed with IBM SPSS Statistics 22nd ver-
sion). For all measurements, higher z-scores indicated better per-
formance on the social cognition tasks or better social skills.
General linear model (GLM-) multivariate analyses of var-
iance were conducted for all participants, then separately for
participants <12 years, 12–17 years and ≥18 years. Within the
separate age-group analyses further statistical control for age
was exerted (by including it as a covariate) when applicable,
as within each age group developmental influences may still
be present. Social cognition-computerized, social cognition-
P&P and social skills (all z-scores) were used as dependent
variables. Analyses were repeated with IQ as a covariate.
Comparisons between BH4-treated and non-BH4-treated pa-
tients were also made using t-tests. Associations between so-
cial outcomes and lifetime/concurrent Phe were investigated
using Pearson’s correlations.
Results
Table 2 shows scores on tasks and questionnaires. Performance
on the computerized tasks was related to performance on the
P&P (r= 0.48, p< 0.001). There were no significant as-
sociations between task-performance and scores on the
questionnaires, indicating they measure different con-
structs, i.e. social cognition versus social skills. Higher
IQ was significantly correlated with performance on the
computerized tasks (r = 0.35, p < 0.001) and P&P
(r= 0.51, p< 0.001).
MANOVAs PKU versus controls
All ages The multivariate effect showed that there was a sig-
nificant difference between patients and controls:
F(3185)= 9.70, p<0.001, η2p=0.14. On all measurements,
controls outperformed or scored better than PKU-patients
(Fig. 1, Table 3). When age was included as a second
independent variable (<12 versus 12–17 versus
≥18 years), the group effect remained significant:
F(3181) = 7.58, p< 0.001, η2p= 0.11. No significant in-
teraction effects between age and group were found,
indicating that the multivariate group differences were
the result of differences between patients and controls
in all age groups. After including IQ as a covariate,
significant group differences remained for social cogni-
tion as measured by P&P-tests and social skills. A com-
parison between BH4 and non-BH4 users, controlling for
age, did not show significant differences. As the lack of
group by age interactions may have been due to de-
creasing statistical power by adding a variable with
three levels (<12 versus 12-17 versus ≥18 years) or to the fact
that cut-offs for developmental stages simply do not lie exact-
ly at 12 and 18 years, we were interested in the results for
separate age groups. Repeating the analyses for the separate
age groups resulted in the following:
Children, age <12 years There were no differences regarding
the multivariate effect or any of the univariate effects
(Table 3), indicating PKU-patients and controls under
the age of 12 scored equally well on the social
cognition-tasks and on the questionnaire assessing social
skills. When including age or IQ as a covariate, results
remained similar.
Adolescents, age 12–17 years The multivariate effect for ad-
olescents was F(3,24)=6.33, p=0.003, η2p=0.44. There was
a significant difference between the adolescent PKU and con-
trol groups on P&P and a trend for social skills (Table 3),
which was irrespective of age and IQ.
Adults, age ≥18 years The multivariate effect was
F(3105)=6.82, p<0.001, η2p=0.16. PKU adults performed
worse than controls on all social measures (Table 3). However,
when including age as covariate, only the differences regard-
ing P&P and social skills remained significant. When IQ was
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taken into account, there was only a significant group differ-
ence for social skills and a trend for P&P. Nonetheless, the
multivariate group effect remained significant after including
age and IQ.
Table 2 Descriptive statistics of all social measurements for PKU and control group, per age group
PKU<12 years Controls < 12 years PKU 12–17 years Controls 12–17 years PKU ≥ 18 years Controls ≥ 18 years
(n= 26) (n= 27) (n = 13) (n= 15) (n = 56) (n = 53)
ANT
FR, % errors 17.0 ± 8.0 15.0 ± 8.4 9.2 ± 4.5 6.8 ± 4.4 7.1 ± 3.5 5.6 ± 3.4
FR, reaction time 1965± 493 1716± 454 1221± 324 1129 ± 174 1197 ± 272 1133 ± 221
IFE, % errors 10.7 ± 6.2 9.6 ± 6.8 8.6 ± 4.9 6.3 ± 2.5 5.7 ± 3.1 4.6 ± 2.5
IFE, reaction time 1304± 276 1082± 263 844 ± 113 807 ± 103 874 ± 182 796 ± 157
P&P
SCST 130.1 ± 23.7 138.3 ± 13.5
RME 22.4 ± 3.4 23.2 ± 2.9 24.4 ± 3.9 26.1 ± 3.6
FPT 49.6 ± 5.0 54.6 ± 2.8 49.2 ± 5.1 51.3 ± 4.6
Questionnaires
SSRS 59.6 ± 11.1 61.3 ± 9.8 60.6 ± 12.3 67.5 ± 7.2
SSC 140.8 ± 17.2 149.9 ± 8.6
ANTAmsterdam neuropsychological tasks, P&P paper-and-pencil tasks, Q questionnaires, FR face recognition, IFE identification of facial emotions,
SCST social cognitive skills task, RME reading the mind in the eyes, FPT faux-pas recognition test, SSRS social skills rating system, SSC social skills
checklist
Note 1. Values are given as mean absolute score and standard deviation
Note 2. P&P and Q: higher score indicates better outcome
ANT = Amsterdam Neuropsychological Tasks; P&P = paper-and-pencil tasks; Q = questionnaires 
*p<0.05 **p<0.01 ***p<0.001 +p<0.10 
Fig. 1 Outcome per age group on
social measures for PKU and
control group (higher z-scores
indicate better outcomes). ANT
Amsterdam neuropsychological
tasks, P&P paper-and-pencil
tasks, Q questionnaires. *p< 0.05
**p< 0.01 ***p < 0.001 +
p< 0.10
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Associations between metabolic control and social
outcomes
All ages Higher lifetime Phe was significantly related to
poorer social skills (r= −0.19, p=0.036). Concurrent Phe
was not significantly related to any of the outcome measures.
Controlling for age or IQ did not alter these associations.
Within the BH4 group, the relationship between lifetime Phe
and social skills was not significant. Examining lifetime Phe
in more detail per age group (<12, 13–17, ≥18 years) gave the
following results:
Children, age <12 years No significant associations between
social measurements and lifetime and concurrent Phe were
observed.
Adolescents, age 12–17 years Significant associations be-
tween P&P and Phe between 8 and 12 years (r=−0.52,
p = 0.033), and between 13 and 17 years (r = −0.51,
p=0.055) were present. There were no significant associa-
tions with concurrent Phe.
Adults, age ≥18 years Lifetime Phe and social skills were
significantly related (r=−0.26, p=0.031). Specifically, social
skilfulness was correlated with Phe between 0 and 7 years
(r=−0.28, p= 0.022), between 8 and 12 years (r=−0.24,
p=0.041) and (almost significantly) between 13 and 17 years
(r = −0.21, p = 0.064). Partial correlations with age as a
covariate showed similar results. No significant associations
with concurrent Phe were observed.
Discussion
Adolescents and adults with PKU show impaired social-
cognitive functioning. Adult patients also report difficulties
with social skills compared to controls. Higher lifetime rather
than concurrent Phe-levels were related to poorer social out-
comes. Strength of effects varied, with larger effect sizes for
group differences between adolescent and adult patients and
their healthy counterparts (cf. Cohen, 1988, 1994). The
strength of correlations between Phe-levels during different
age-periods and social and social-cognitive outcomes also var-
ied with moderate-to-large associations for Phe between 0 and
12 years and social-cognitive functioning of adolescent pa-
tients and social skills of adult patients. Despite the fact that
it remains difficult to judge the importance of these statistical-
ly meaningful results, evidence is provided that there are Phe-
related problems with social-cognitive abilities and social
skills in PKU, which, considering their importance for several
other functional domains and everyday life, should therefore
feature in treatment and monitoring.
Phe between 0 and 7 years was higher for the adult patients
than for the PKU children and adolescents, possibly indicating
changes in treatment regimen throughout the years. As our
results showed that low Phe during childhood and early adoles-
cence is important for social functioning later in life, this might
indicate good news for the current generation of children (and
adolescents) with PKU. PKU children in the present study gen-
erally had Phe-levels below the recommended upper target
levels (360 μmol/L) and there were no differences with healthy
controls and no associations between Phe-levels and social out-
comes for this age group. Mean lifetime Phe-levels were below
the upper target limit for adolescents (600 μmol/L) as well, but
they had poorer social-cognitive abilities than their healthy
counterparts. These findings could be interpreted as evidence
for recommending even lower upper target levels throughout
childhood or at least adolescence. However, social (-cognitive)
functioning of PKU-patients may be determined by many other
factors in addition to Phe-levels. Considering the additional
burden (which might even work counterproductively when so-
cial functioning is concerned) of an even stricter treatment reg-
imen, it would be premature to interpret these results as evi-
dence supporting the lowering of upper target Phe-levels.
Patients using BH4 had lower lifetime and concurrent Phe,
probably partly because BH4-responsive patients generally
present with milder forms of PKU, and partly because of the
treatment itself. There were no differences in social outcomes
between the BH4 and non-BH4 groups. Also, no associations
between Phe and social measures in the BH4 group were
found. Thus, inclusion of patients using BH4 may have
Table 3 Statistical
overview MANOVAs
for PKU versus controls
F df η2p
All ages
ANT 6.07* 1187 0.031
P&P 14.95*** 1187 0.074
Q 12.92*** 1187 0.065
Age <12 years
ANT 0.38 1,50 0.008
P&P 1.40 1,50 0.027
Q 0.29 1,50 0.006
Age 12–17 years
ANT 2.39 1,26 0.084
P&P 7.19* 1,26 0.217
Q 3.42+ 1,26 0.116
Age ≥18 years
ANT 4.42* 1107 0.040
P&P 9.12** 1107 0.079
Q 13.22*** 1107 0.110
ANT Amsterdam neuropsychological
tasks, P&P paper-and-pencil tasks, Q
questionnaires
*p < 0.05 **p < 0.01 ***p < 0.001 +
p < 0.10
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resulted in fewer-than-expected associations between Phe and
social outcomes. It is also possible that lowering Phe-levels
through BH4 simply does not result in better social-cognitive
abilities and social skills, or only does so in the longer term.
The present study also showed that deficits in social skills
were not fully explained by impaired general cognitive ability.
The possibility still exists that EF is a larger contributor to social
skills than IQ. As EF-problems are the most prominent cogni-
tive deficits observed in PKU, future studies should examine
associations between EF and social outcomes in more detail.
Furthermore, factors such as family functioning, upbringing by
parents (e.g. being overprotected), dietary compliance and con-
tents, level of stress experienced either through coping with
PKU or through other sources (e.g. parental divorce) should
be taken into account when investigating social functioning in
PKU (MacDonald et al 2010; Olsson et al 2007).
The fact that, for this study, we did not take into account
many other factors, apart from Phe-levels, that might be related
to social outcomes may be considered a limitation. Another
issue that needs to be taken into account is that all patients were
recruited through treatment centres, which implies that, at least,
they were followed up (regardless of how well they adhered to
their treatment regimens). Patients lost to follow-up may very
well show higher Phe-levels (as there is no external monitoring
in place at all) and subsequent poorer social (-cognitive) func-
tioning. Thus, in reality, when all patients are considered, group
differences and associations between social (-cognitive) func-
tioning and Phe could be more pronounced. It may also be
considered a limitation that we used parent- and self-reports to
measure social skills. Although it is very difficult to assess
social functioning in laboratory settings (which generally do
not mimic daily life situations very well), it is possible that
reports partly depended on social metacognition. However, in
this respect it is noteworthy that group differences regarding
social skills remained significant after statistical control for gen-
eral cognitive ability. A further issue that warrants attention in
future studies is that differential prediction from Phe-levels dur-
ing different age periods is complicated by the fact that they are
generally related, which could lead to multicollinearity.
Therefore, in future studies it would be preferable if different
statistical approaches could be taken, that distinguish develop-
mental patterns or trajectories of Phe-levels.
The present study demonstrates deficits in core social (-
cognitive) abilities. The influence of Phe during childhood
and early adolescence seems to be important for social-
cognitive functioning and social skills later in life. Overall,
this study showed the importance of assessment of social (-
cognitive) functioning in PKU-patients.
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